Search
EN

Over the deal

Investec acted as the Exclusive Financial Advisor to Everstone and other selling shareholders, enabling them to successfully exit OmniActive Health Technologies (“OmniActive”) at a total deal size of USD 150 million. TA Associates, a Global Private Equity Fund, acquired 54% stake in OmniActive.

About OmniActive

OmniActive is a leading player supplying natural active ingredients catering to the dietary supplement, nutritional fortification and functional food industries. OmniActive offers a range of branded, clinically proven, and scientifically verified ingredients that enable nutrition brands around the world to provide supplements that meet the demands of the dynamic health and wellness market. Bolstered by tier-1 customers such as Bausch & Lomb, GNC, Costco, etc. OmniActive boasts strong fundamental demand from both international and domestic clientele.

What we did

  • Investec ran a wide, intensely competitive process involving global funds to ensure optimum value creation for the Selling Shareholders and OmniActive.
  • Investec played a quarterback role to ensure the definitive documentation package reflected the interests of the various selling shareholders and founder in a compressed time frame and played a key role in stitching together a deal to balance interests of the promoter and incoming investors and create a foundation for a long-term partnership.
Deal Type
Target Headquarter
Date
January 2021
Parties

Subscribe to our Insights

    Sector preference